IC
VERV

IEQ Capital’s Verve Therapeutics VERV Stock Holding History

IEQ Capital’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,648
Closed -$164K – 2086
2025
Q2 		$164K Sell
14,648
-54,522
-79% -$311K ﹤0.01% 1651
2025
Q1 		$316K Buy
+69,170
New +$463K ﹤0.01% 1163

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IEQ Capital's VERV Position: Q3 2025 in Review

IEQ Capital sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 14,648 shares — an estimated $164K sold.

IEQ Capital first reported a position in VERV in Q1 2025 and held it in 2 quarters. The position peaked at $316K in Q1 2025. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • IEQ Capital reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • IEQ Capital sold 14,648 Verve Therapeutics shares in Q3 2025, an estimated $164K.
  • IEQ Capital first reported a position in Verve Therapeutics in Q1 2025 and held it in 2 quarters.
  • IEQ Capital's Verve Therapeutics position peaked at $316K in Q1 2025.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on IEQ Capital's 13F filing for Q3 2025, filed 14 Nov 2025.